Welcome to our dedicated page for F&G Annuities & Life SEC filings (Ticker: FGSN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on F&G Annuities & Life's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into F&G Annuities & Life's regulatory disclosures and financial reporting.
F&G Annuities & Life, Inc. (FG) reported an insider equity award for its EVP, General Counsel & Corporate Secretary. On 11/10/2025, the officer received a grant of 9,194 shares of restricted common stock at a stated price of $0, reflecting a stock-based compensation award rather than a market purchase. Following this grant, the officer beneficially owns 42,734 shares of FG common stock in direct ownership. The restricted shares are scheduled to vest in three equal annual installments beginning on November 10, 2026, and vesting is subject to performance criteria defined in the award agreement, meaning the officer must meet specified targets for the shares to fully vest.
F&G Annuities & Life, Inc. (FG) reported an insider equity award to one of its directors. On November 10, 2025, the director acquired 6,436 shares of common stock coded as an acquisition at a stated price of $0, indicating a grant rather than an open-market purchase. After this grant, the director beneficially owns 24,306 shares directly, plus 41 shares indirectly through a 401(k) and 152,696 shares indirectly through the Quirk 2002 Trust. The award is described as restricted stock that will vest in three equal annual installments beginning November 10, 2026, meaning the director receives full ownership over time as the vesting conditions are met.
F&G Annuities & Life (FG) reported a director equity grant on 11/10/2025. The filing shows an award of 6,436 restricted common shares at $0 (Code A), increasing the director’s holdings.
Following the transaction, the director beneficially owns 57,038 shares directly and 753 shares indirectly through the Michael J. Nolan Trust. The grant vests in three equal annual installments beginning November 10, 2026.
F&G Annuities & Life, Inc. (FG) reported a director equity grant on a Form 4. On 11/10/2025, the director received 6,436 shares of restricted common stock at $0 per share.
The award vests in three equal annual installments beginning November 10, 2026. Following this grant, the director beneficially owns 54,164 shares, held directly.
F&G Annuities & Life, Inc. (FG) reported a stock grant to a director. On 11/10/2025, a director received 6,436 shares of restricted common stock at a price of $0, increasing the director’s beneficial ownership to 26,532 shares held directly. The restricted stock is scheduled to vest in three equal annual installments beginning on November 10, 2026, meaning one‑third of the shares will become fully owned each year over that period. This filing reflects an equity-based compensation award rather than an open-market purchase or sale.
F&G Annuities & Life, Inc. (FG) reported an insider equity grant on a Form 4. A director received 6,436 shares of restricted common stock on November 10, 2025 at a stated price of $0, indicating it was an award rather than an open‑market purchase. These restricted shares vest in three equal annual installments beginning November 10, 2026, meaning the director gains full ownership gradually over three years as long as vesting conditions are met. Following this grant, the director beneficially owns 27,310.79 shares of FG common stock directly. This filing reflects routine equity-based compensation used to align director interests with shareholders.
F&G Annuities & Life (FG) reported an insider equity award. The EVP, Chief Investment Officer received 21,913 shares of restricted common stock on November 10, 2025 at a stated price of $0. The award vests in three equal annual installments beginning November 10, 2026, contingent on performance criteria in the award agreement.
Following this transaction, the reporting person beneficially owned 85,977 shares, held directly.
F&G Annuities & Life (FG) reported an insider equity award. The EVP, CLO & Treasurer acquired 38,769 shares of restricted common stock on November 10, 2025 at $0.
The grant vests in three equal annual installments beginning November 10, 2026, subject to performance criteria specified in the award agreement. Following the transaction, the reporting person beneficially owns 119,759.5467 shares. The filing also notes purchases under the company’s ESPP are included to accurately reflect current ownership.
F&G Annuities & Life (FG) reported an insider equity award. The President and CFO received 122,587 shares of restricted common stock on 11/10/2025 at a grant price of $0. The award vests in three equal annual installments beginning November 10, 2026, subject to performance criteria in the award agreement. Following the reported transactions, the officer beneficially owns 204,830.012 shares. The filing also reflects purchases under the company’s ESPP to align reported ownership with current holdings.
F&G Annuities & Life (FG) reported a Form 4 for its Chief Executive Officer and Director. On 11/10/2025, the insider acquired 260,497 shares of restricted common stock at $0. The award vests in three equal annual installments beginning November 10, 2026, subject to performance criteria in the award agreement. Following these transactions and ESPP updates, direct beneficial ownership stands at 1,169,753.6075 shares.